CCR5 Is a Therapeutic Target for Recovery after S
Post# of 148110
(Total Views: 444)
Posted On: 08/24/2023 10:36:40 AM
CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury: Cell
Finally, in a large clinical cohort of stroke patients, carriers for a naturally occurring loss-of-function mutation in CCR5 (CCR5-Δ32) exhibited greater recovery of neurological impairments and cognitive function. In summary, CCR5 is a translational target for neural repair in stroke and TBI and the first reported gene associated with enhanced recovery in human stroke.
And the stock sits at 0.20 ???
Finally, in a large clinical cohort of stroke patients, carriers for a naturally occurring loss-of-function mutation in CCR5 (CCR5-Δ32) exhibited greater recovery of neurological impairments and cognitive function. In summary, CCR5 is a translational target for neural repair in stroke and TBI and the first reported gene associated with enhanced recovery in human stroke.
And the stock sits at 0.20 ???
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼